Literature DB >> 10663214

Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight.

C Weyer1, K Hanson, C Bogardus, R E Pratley.   

Abstract

AIMS/HYPOTHESIS: We aimed to quantify changes in insulin action and insulin secretion associated with long-term gain, loss, regain, and maintenance of body weight in subjects with normal (NGT) or impaired (IGT) glucose tolerance.
METHODS: Insulin action (hyperinsulinaemic clamp) and insulin secretion (intravenous glucose challenge) were measured longitudinally in 209 Pima Indians body weight 94.4 +/- 22.8 kg (means +/- SD) 89 women/120 men, 151 NGT/58 IGT[, who either lost (n = 110) or gained (n = 99) weight (-23% to +29%) over 2.6 +/- 2.0 years. Insulin action and insulin secretion were reassessed on a third occasion in 33 subjects who lost at least 5% body weight over 1.5 +/- 0.8 years and then either regained or maintained weight over the subsequent 1.8 +/- 1.1 years.
RESULTS: There was a linear negative relation between changes in body weight and changes in insulin-stimulated glucose disposal in subjects with normal glucose tolerance (r = -0.51, p < 0.0001) and impaired glucose tolerance (r = -0.54, p < 0.0001). In contrast, changes in the acute insulin response were positively related to weight changes in subjects with normal glucose tolerance (r = +0.26, p < 0.005) but negatively in those with impaired glucose tolerance (r = -0.51, p < 0.0001). Improvements in insulin action after an average of 10% weight loss were lost with weight regain but largely preserved with weight maintenance. CONCLUSION/
INTERPRETATION: Improvements in insulin action are proportional to the amount of weight loss, similar in magnitude to the impairment in insulin action with weight gain, preserved with long-term weight maintenance and similar between subjects with normal and with impaired glucose tolerance. Weight gain could, however, have more detrimental effects in people with impaired glucose tolerance, in whom insulin secretion decreases rather than increases to compensate for the decreased insulin action.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663214     DOI: 10.1007/s001250050005

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents.

Authors:  Tammy L Kindel; Paulo J F Martins; Stephanie M Yoder; Ronald J Jandacek; Randy J Seeley; David A D'Alessio; Silvana Obici; Patrick Tso
Journal:  Obesity (Silver Spring)       Date:  2010-10-28       Impact factor: 5.002

2.  Hostility and minimal model of glucose kinetics in African American women.

Authors:  Richard S Surwit; James D Lane; David S Millington; Haoyue Zhang; Mark N Feinglos; Sharon Minda; Rhonda Merwin; Cynthia M Kuhn; Raymond C Boston; Anastasia Georgiades
Journal:  Psychosom Med       Date:  2009-06-26       Impact factor: 4.312

Review 3.  A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.

Authors:  Adrian Bagust; Marc Evans; Sophie Beale; Philip D Home; Andrew S Perry; Murray Stewart
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Incident diabetes in relation to weight patterns during middle age.

Authors:  Molly E Waring; Charles B Eaton; Thomas M Lasater; Kate L Lapane
Journal:  Am J Epidemiol       Date:  2010-01-28       Impact factor: 4.897

Review 5.  Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.

Authors:  Richard E Pratley; Christian Weyer
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

6.  Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka-Long-Evans-Tokushima fatty rat.

Authors:  M Otani; M Yamamoto; M Harada; M Otsuki
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

7.  Pre-transplant weight but not weight gain is associated with new-onset diabetes after transplantation: a multi-centre cohort Spanish study.

Authors:  Domingo Marrero; Domingo Hernandez; Lourdes Pérez Tamajón; Manuel Rivero; Ildefonso Lampreabe; Maria Dolores Checa; Jose Manuel Gonzalez-Posada
Journal:  NDT Plus       Date:  2010-06

Review 8.  Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?

Authors:  André J Scheen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Is beta-cell failure in type 2 diabetes mellitus reversible?

Authors:  Rashmi Jain; Udaya Kabadi; M Kabadi
Journal:  Int J Diabetes Dev Ctries       Date:  2008-01

10.  Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein.

Authors:  Anny H Xiang; Miwa Kawakubo; Enrique Trigo; Siri L Kjos; Thomas A Buchanan
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.